Processa Pharmaceuticals (PCSA) Return on Equity [ROE] (2013 - 2026)
Processa Pharmaceuticals' Return on Equity [ROE] was -1160.68% in Q2 2026, down 897.72 percentage points from -262.96% a year earlier and down 802.99 percentage points from the prior quarter.
Powered by 
Analysis
Processa Pharmaceuticals (PCSA) Return on Equity [ROE] (2013 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Processa Pharmaceuticals came in at -372.97%, down 18.46 percentage points from FY2024.
- Return on Equity [ROE] has now declined for four consecutive years, with a five-year change of -279.83 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -354.51% in FY2024 (-175.99 pp), -178.52% in FY2023 (-12.09 pp), -166.43% in FY2022 (-119.23 pp) and -47.20% in FY2021 (+45.94 pp).
- The Q2 2026 figure marks the lowest quarterly Return on Equity [ROE] since Q3 2014.
- Compared with a year earlier, Return on Equity [ROE] was higher in four of the last eight quarters, with an average year-over-year change of -155.58 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q4 2025 (a gain of 190.14 percentage points); the worst was Q2 2026 (a drop of 897.72 percentage points).
- Per Business Quant data, PCSA's Return on Equity [ROE] in the three quarters before Q2 2026 was -357.68% (Q1 2026), -244.96% (Q4 2025) and -213.90% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Processa Pharmaceuticals | 4.58 Mn | 4.58 Mn | - | -1,160.68% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,160.68% |
| Mar 31, 2026 | -357.68% |
| Dec 31, 2025 | -244.96% |
| Sep 30, 2025 | -213.90% |
| Jun 30, 2025 | -262.96% |
| Mar 31, 2025 | -449.03% |
| Dec 31, 2024 | -435.09% |
| Sep 30, 2024 | -239.99% |
| Jun 30, 2024 | -139.40% |
| Mar 31, 2024 | -144.06% |
| Dec 31, 2023 | -182.96% |
| Sep 30, 2023 | -266.16% |
| Jun 30, 2023 | -265.96% |
| Mar 31, 2023 | -320.44% |
| Dec 31, 2022 | -221.96% |
| Sep 30, 2022 | -94.29% |
| Jun 30, 2022 | -67.23% |
| Mar 31, 2022 | -51.54% |
| Dec 31, 2021 | -43.37% |
| Sep 30, 2021 | -63.70% |
API Access
Processa Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PCSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PCSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PCSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();